Cellectar Biosciences Files 8-K
Ticker: CLRB · Form: 8-K · Filed: Jan 14, 2025 · CIK: 1279704
| Field | Detail |
|---|---|
| Company | Cellectar Biosciences, Inc. (CLRB) |
| Form Type | 8-K |
| Filed Date | Jan 14, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.00001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, corporate-filing
TL;DR
Cellectar filed an 8-K on Jan 14 for Jan 12 events. Standard disclosure.
AI Summary
Cellectar Biosciences, Inc. filed an 8-K on January 14, 2025, reporting events as of January 12, 2025. The filing indicates a Regulation FD Disclosure and includes Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided text, but the filing itself is a standard corporate disclosure.
Why It Matters
This 8-K filing serves as a public record of important corporate events or disclosures for Cellectar Biosciences, Inc., providing transparency to investors.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for disclosures and exhibits, not indicating any immediate negative or positive material events.
Key Players & Entities
- Cellectar Biosciences, Inc. (company) — Registrant
- January 12, 2025 (date) — Earliest event date
- January 14, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Florham Park, NJ (location) — Principal executive offices
FAQ
What specific events are being disclosed in this 8-K filing?
The provided text indicates the filing is for 'Regulation FD Disclosure' and 'Financial Statements and Exhibits' as of January 12, 2025, but does not detail the specific events.
When was this 8-K filed with the SEC?
The 8-K was filed on January 14, 2025.
What is the principal executive office address for Cellectar Biosciences, Inc.?
The principal executive offices are located at 100 Campus Drive, Florham Park, NJ, 07932.
What is the SIC code for Cellectar Biosciences, Inc.?
The Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
What is the Commission File Number for Cellectar Biosciences, Inc.?
The Commission File Number is 001-36598.
Filing Stats: 464 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2025-01-14 06:01:27
Key Financial Figures
- $0.00001 — ch registered Common Stock, par value $0.00001 per share CLRB The Nasdaq Capital M
Filing Documents
- tm253236d1_8k.htm (8-K) — 26KB
- tm253236d1_ex99-1.htm (EX-99.1) — 15KB
- tm253236d1_ex99-1img01.jpg (GRAPHIC) — 6KB
- 0001104659-25-003208.txt ( ) — 221KB
- clrb-20250112.xsd (EX-101.SCH) — 3KB
- clrb-20250112_lab.xml (EX-101.LAB) — 33KB
- clrb-20250112_pre.xml (EX-101.PRE) — 22KB
- tm253236d1_8k_htm.xml (XML) — 3KB
01
Item 7.01. Results of Operations and Financial Condition. On January 12, 2025, we issued a press release with an overview of the Company's 2025 strategic initiatives that we will be presenting at Biotech Showcase during the JP Morgan healthcare conference. A copy of the press release is furnished as Exhibit 99.1 and is incorporated by reference herein.
Financial Statements and Exhibits
Financial Statements and Exhibits (d) Exhibits Number Title 99.1 Press release dated January 12, 2025, titled "Cellectar Biosciences to Highlight 2025 Strategic Initiatives at Upcoming Biotech Showcase during the JP Morgan Healthcare Conference" 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CELLECTAR BIOSCIENCES, INC. Date: January 14, 2025 By: /s/ Chad J. Kolean Name: Chad J. Kolean Title: Chief Financial Officer